NIOX Group (LON:NIOX) Posts Earnings Results

NIOX Group (LON:NIOX) issued its earnings results on Wednesday. The company reported GBX 1.41 earnings per share (EPS) for the quarter, Digital Look Earnings reports. NIOX Group had a net margin of 14.74% and a return on equity of 10.01%.

NIOX Group Stock Performance

Shares of LON NIOX traded down GBX 3 during trading on Thursday, reaching GBX 66. 215,753 shares of the company traded hands, compared to its average volume of 799,601. The firm’s fifty day simple moving average is GBX 65.69 and its 200 day simple moving average is GBX 61.63. The stock has a market cap of £277.77 million, a P/E ratio of 40.24 and a beta of 0.92. NIOX Group has a 12-month low of GBX 53.84 and a 12-month high of GBX 76. The company has a current ratio of 4.60, a quick ratio of 1.94 and a debt-to-equity ratio of 1.06.

About NIOX Group

NIOX Group plc is a medical technology company focused on improving the lives of millions of people suffering from respiratory health issues globally. NIOX develops and markets innovative, non-invasive diagnostic products for chronic airway diseases, primarily asthma and COPD. Its lead product, NIOX VERO®, enables the accurate measurement of fractional exhaled nitric oxide (FeNO), an established biomarker for airway inflammation, supporting better diagnosis, monitoring and management of asthma and COPD in clinical and research settings.

Headquartered in the UK and listed on the London Stock Exchange (ticker: NIOX), the company operates internationally, serving healthcare professionals in over 50 countries.